Provided by Tiger Fintech (Singapore) Pte. Ltd.

Therapeutics

24.75
+0.15000.61%
Post-market: 24.750.00000.00%16:20 EDT
Volume:189.40K
Turnover:4.66M
Market Cap:680.65M
PE:-9.21
High:25.47
Open:24.52
Low:23.64
Close:24.60
Loading ...

Alterity Therapeutics to Quote New Securities on ASX

TIPRANKS
·
2 hours ago

Xilio Therapeutics: Strategic Pivot and Promising Pipeline Drive Buy Rating

TIPRANKS
·
4 hours ago

Cadrenal Therapeutics FY 2024 GAAP EPS $(8.73) Misses $(7.59) Estimate

Benzinga
·
9 hours ago

Press Release: Candel Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights

Dow Jones
·
9 hours ago

Allogene Therapeutics: Q4 Earnings Snapshot

Associated Press Finance
·
9 hours ago

Press Release: Intensity Therapeutics Reports 2024 Year End Financial Results and Provides Corporate Update

Dow Jones
·
10 hours ago

Press Release: Cadrenal Therapeutics Reports Full Year 2024 Results, Business Highlights, and Path Forward for Clinical Advancement of Tecarfarin

Dow Jones
·
10 hours ago

Cognition Therapeutics to Report Fourth Quarter and Full Year 2024 Results

GlobeNewswire
·
10 hours ago

Allogene Therapeutics Q4 EPS $(0.28) Beats $(0.33) Estimate

Benzinga
·
10 hours ago

Allogene Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update

GlobeNewswire
·
10 hours ago

Tenaya Therapeutics Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
13 hours ago

Promising Clinical Data and Financial Stability Support Buy Rating for Tenaya Therapeutics Despite Price Target Reduction

TIPRANKS
·
Yesterday

Promising Investment in Werewolf Therapeutics: Strong Financials and Strategic Partnerships Drive Growth Prospects

TIPRANKS
·
Yesterday

Buy Rating for Contineum Therapeutics: Promising Pipeline and Market Opportunities

TIPRANKS
·
Yesterday

Dogwood Therapeutics Launches Registered Direct Offering; Shares Plunge

MT Newswires Live
·
Yesterday

Transcode Therapeutics Price Target Maintained With a $20.00/Share by HC Wainwright & Co.

Dow Jones
·
Yesterday